Highlights of the 12th Japan Bioanalysis Forum Symposium

Approximately 300 people associated with pharmaceutical industries, contractors, academic institutions and regulatory authorities attended the 12th Japan Bioanalysis Forum Symposium. The webinar was conducted from 9 to 11 March 2021. The theme of the symposium was ‘for the next generation’, and the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioanalysis 2021-11, Vol.13 (22), p.1653-1657
Hauptverfasser: Uchiyama, Hitoshi, Yamaguchi, Takeru, Arai, Koji, Arakawa, Tomoko, Igarashi, Harue, Ohtsu, Yoshiaki, Ochiai, Ryosuke, Kawai, Yosuke, Koseki, Nozomu, Komaba, Junji, Sano, Yoshihisa, Shimizu, Hisao, Takahashi, Makoto, Nagao, Akemi, Nakamura, Takahiro, Nishiguchi, Yumi, Hata, Katsutomo, Nakai, Keiko, Hara, Hisanori, Mabuchi, Masanari, Murao, Naoaki, Yoshinaga, Ryosuke
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Approximately 300 people associated with pharmaceutical industries, contractors, academic institutions and regulatory authorities attended the 12th Japan Bioanalysis Forum Symposium. The webinar was conducted from 9 to 11 March 2021. The theme of the symposium was ‘for the next generation’, and the event provided ‘an opportunity for young researchers in bioanalysis (including students)’ and ‘an opportunity to discuss new frontiers of bioanalysis’. The speakers focused on hot topics of bioanalysis, including biomarker analysis, patient centric sampling, virtual clinical trials, gene therapy, cancer genome medicine and therapeutic middle molecules. The symposium presented a platform for the discussion of the prospects and challenges facing bioanalysts working in the field of pharmacokinetics. This report presents the key issues discussed.
ISSN:1757-6180
1757-6199
DOI:10.4155/bio-2021-0204